HCIdea® is a product of the National Council for Prescription Drug Programs (NCPDP), a trusted provider of data to the healthcare industry for three decades. While NCPDP may be best known for developing national standards for electronic healthcare transactions, we also have a track record for developing quality database products driven by industry needs.
NCPDP pioneered the development of a national pharmacy database back in the 1980s. We continue to maintain and enhance that product, known today as dataQ®, a trusted source of quality data on pharmacies nationwide. In 2005, we introduced our HCIdea® database product, providing comprehensive profiles of prescribers nationwide. With both products, NCPDP’s laser focus has been on consistently improving data quality. It is this focus that led us to partner with Medversant to power HCIdea with patented autoverification technology for the cleanest prescriber data on the market today.
Medversant, a leader in technology solutions for the management of provider information, invested 12 years in developing the AutoVerifi® technology (US Patent Numbers 7,529,682 and 8,131,558). This is the only provider database management technology in the industry that electronically and automatically accesses, verifies and updates provider information from thousands of primary and approved authoritative sources.
Its patented autoverification technology is integral to Medversant’s role in credentialing providers for more than 235 healthcare organizations. Medversant is an NCQA certified, URAC accredited, Joint Commission and CMS compliant Credentials Verification Organization (CVO). As a CVO, Medversant conducts credentials verification, reports the credentialing information to healthcare organization clients, and has systems in place to protect the confidentiality and integrity of the information.
NCPDP owns the HCIdea database and to ensure the highest level of accuracy and timeliness, HCIdea data is supplied and maintained by Medversant. Together, NCPDP and Medversant support HCIdea subscribers with data updates and responsive client service.
* AutoVerifi™ is a patented Medversant technology (US Patent Numbers 7,529,682 and 8,131,558)